Vir Biotechnology (VIR) PT Lowered to $25 at Morgan Stanley
Morgan Stanley analyst Michael Ulz ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)